Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT00772200 : Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
PhaseN/A
AgesMin: 3 Years Max: 21 Years
Eligibility
DISEASE CHARACTERISTICS:

- Histologically confirmed diagnosis of medulloblastoma or supratentorial primitive
neuroectodermal tumor (PNET)

- Must be currently enrolled on a COG therapeutic study that aims to examine
neuropsychological, social, emotional, and/or behavioral functioning

PATIENT CHARACTERISTICS:

- Must have receptive and expressive English language skills

- Patients with a history of severe or profound mental retardation (i.e., IQ < 50) are
not eligible for enrollment

- Children with a prior history of attention-deficit hyperactivity disorder (ADHD)
or a specific learning disability (e.g., dyslexia) are eligible for this study

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT00772200      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740